9F2I
 
 | | Crystal structure of SARS-CoV-2 N-protein C-terminal domain in complex with 2-amino-1,3-benzothiazol-6-ol | | Descriptor: | 1,2-ETHANEDIOL, 2-amino-1,3-benzothiazol-6-ol, Nucleoprotein, ... | | Authors: | Marquez-Monino, M.A, Gonzalez, B, Perez-Canadillas, J.M. | | Deposit date: | 2024-04-23 | | Release date: | 2024-11-13 | | Last modified: | 2025-01-15 | | Method: | X-RAY DIFFRACTION (1.45 Å) | | Cite: | The ALS drug riluzole binds to the C-terminal domain of SARS-CoV-2 nucleocapsid protein and has antiviral activity.
Structure, 33, 2025
|
|
9F2G
 | |
9F2H
 | | Crystal structure of SARS-CoV-2 N-protein C-terminal domain in complex with riluzole | | Descriptor: | 1,2-ETHANEDIOL, 6-(trifluoromethoxy)-1,3-benzothiazol-2-amine, Nucleoprotein, ... | | Authors: | Marquez-Monino, M.A, Gonzalez, B, Perez-Canadillas, J.M. | | Deposit date: | 2024-04-23 | | Release date: | 2024-11-13 | | Last modified: | 2025-01-15 | | Method: | X-RAY DIFFRACTION (1.3 Å) | | Cite: | The ALS drug riluzole binds to the C-terminal domain of SARS-CoV-2 nucleocapsid protein and has antiviral activity.
Structure, 33, 2025
|
|
